EMA/PE/0000183220 - paediatric investigation plan

iclepertin

Key facts

• Active substance:
  iclepertin
• Therapeutic area:
  Psychiatric disorders
• Decision number:
  EMA/PE/0000183220
• PIP number:
  EMA/PE/0000183220
• Pharmaceutical form(s):
  Film-coated tablet
• Condition(s) / indication(s):
  Treatment of schizophrenia
• Route(s) of administration:
  Oral use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  22/11/2024
• Compliance check done:
  No

Decision

EMA/PE/0000183220: EMA decision of 22 November 2024 on the acceptance of a modification of an agreed paediatric investigation plan for iclepertin

Adopted Reference Number: EMADOC-1700519818-1766863